» Articles » PMID: 39470741

A Recent Update on the Antibacterial Effects Of distinct Bioactive Molecules Derived from The Cannabis Plant

Overview
Publisher Akademiai Kiado
Date 2024 Oct 29
PMID 39470741
Authors
Affiliations
Soon will be listed here.
Abstract

The number of human infections with multidrug-resistant (MDR) bacteria is increasing worldwide and constitutes a serious threat to human health. Given the lack of novel antibiotic compounds worsening this dilemma, alternative antibiotic-independent treatment and prevention strategies of infectious diseases applying natural compounds appear highly appreciable. Given the long-known health-beneficial and disease-alleviating properties of Cannabis, we performed a literature search summarizing current knowledge regarding the antibacterial effects of extracts from different parts of the Cannabis sativa plant and of defined Cannabis-derived molecules and their potential mode of action. The included studies revealed that various extracts and essential oils of C. sativa as well as major cannabinoids exerted potent activities against a broad spectrum of Gram-positive bacteria and against some Gram-negative bacterial species including MDR strains. Particularly the disruption of the bacterial cytoplasmic membrane by some cannabinoids resulted in potent antibacterial effects against Gram-positive bacteria including methicillin-resistant Staphylococcus aureus. Furthermore, defined cannabinoids inhibited the formation of and eradicated existing bacterial biofilms. In conclusion, given their antibacterial properties distinct Cannabis-derived molecules expand the repertoire of antibiotics-independent treatment options in the combat of bacterial infectious diseases which should be further addressed in future studies including clinical trials.

References
1.
Armassa N, Wongsorn D, Saenmahayak B, Rayan S, Rattanasuk S . Antibacterial Activity of Ethanolic Tanao Si Kan Dang RD1 ( L.) Extracts Against Human Antibiotic-Resistant Bacteria. Pak J Biol Sci. 2024; 27(3):119-124. DOI: 10.3923/pjbs.2024.119.124. View

2.
Crocq M . History of cannabis and the endocannabinoid system
. Dialogues Clin Neurosci. 2020; 22(3):223-228. PMC: 7605027. DOI: 10.31887/DCNS.2020.22.3/mcrocq. View

3.
. Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis. Lancet. 2022; 399(10325):629-655. PMC: 8841637. DOI: 10.1016/S0140-6736(21)02724-0. View

4.
Guillouard M, Authier N, Pereira B, Soubrier M, Mathieu S . Cannabis use assessment and its impact on pain in rheumatologic diseases: a systematic review and meta-analysis. Rheumatology (Oxford). 2020; 60(2):549-556. DOI: 10.1093/rheumatology/keaa534. View

5.
Sangkanu S, Pitakbut T, Phoopha S, Khanansuk J, Chandarajoti K, Dej-Adisai S . A Comparative Study of Chemical Profiling and Bioactivities between Thai and Foreign Hemp Seed Species ( L.) Plus an In-Silico Investigation. Foods. 2024; 13(1). PMC: 10778124. DOI: 10.3390/foods13010055. View